New Market Study Published: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2012
Global Markets Direct's, 'Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Kidney Cancer (Renal Cell Cancer), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Kidney Cancer (Renal Cell Cancer). Kidney Cancer (Renal Cell Cancer) - Pipeline Review, Half Year is built using data and information sourced...
View full press release